Disparate effects of two phosphatidylcholine binding proteins, C-reactive protein and surfactant protein A, on pulmonary surfactant structure and function

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 287, Issue 6 31-6, 2004, Pages

  Nag, Kaushik ^a,f   Rodriguez Capote, Karina ^a,d   Panda, Amiya Kumar ^a,e   Frederick, Laura ^a   Hearn, Stephen A ^b   Petersen, Nils O ^a   Schürch, Samuel ^c   Possmayer, Fred ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ST JOSEPH S HEALTH CENTRE   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d INSTITUTO DE CIENCIAS BÁSICAS Y PRECLÍNICAS VICTORIA DE GIRÓN   (Cuba)

^e BEHALA COLLEGE   (India)

^f MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Acute respiratory distress syndrome; Captive bubble tensiometer; Electron microscopy; Surface tension; Surfactant biophysical impairment

Indexed keywords

BOVINE LIPID EXTRACT SURFACTANT; C REACTIVE PROTEIN; LUNG SURFACTANT; PHOSPHATIDYLCHOLINE; PHOSPHORYLCHOLINE; SURFACTANT PROTEIN A; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; BINDING AFFINITY; ELECTRON MICROSCOPY; HOST RESISTANCE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BINDING; SURFACE TENSION;

ADSORPTION; ANIMALS; C-REACTIVE PROTEIN; CATTLE; LUNG; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANTS;

EID: 8644240275     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00408.2003     Document Type: Article

References (61)

1. Amirkhanian JD and Taeusch HW. Reversible and irreversible inactivation of preformed pulmonary surfactant surface films by changes in subphase constituents. Biochim Biophys Acta 1165: 321-326, 1993.
2. Bernhard W, Hoffmann S, Dombrowsky H, Rau GA, Kamlage A, Kappler M, Haitsma JJ, Freihorst J, von der Hardt H, and Poets CF. Phosphatidylcholine molecular species in lung surfactant: composition in relation to respiratory rate and lung development. Am J Respir Cell Mol Biol 25: 725-731, 2001.
3. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
4. Casals C, Varela A, Ruano ML, Valino F, Perez-Gil J, Torre N, Jorge E, Tendillo F, and Castillo-Olivares JL. Increase of C-reactive protein and decrease of surfactant protein A in surfactant after lung transplantation. Am J Respir Crit Care Med 157: 43-49, 1998.
5. Chang MK, Binder CJ, Torzewski M, and Witztum JL. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA 99: 13043-13048, 2002.
6. Chung J, Yu SH, Whitsett JA, Harding PG, and Possmayer F. Effect of surfactant-associated protein-A (SP-A) on the activity of lipid extract surfactant. Biochim Biophys Acta 1002: 348-358, 1989.
7. Cockshutt AM, Weitz J, and Possmayer F. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29: 8424-8429, 1990.
8. Dong Q and Wright JR. Expression of C-reactive protein by alveolar macrophages. J Immunol 156: 4815-4820, 1996.
9. Frerking I, Gunther A, Seeger W, and Pison U. Pulmonary surfactant: functions, abnormalities and therapeutic options. Intensive Care Med 27: 1699-1717, 2001.
10. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1408: 79-89, 1998.
11. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 13: 1455-1476, 1999.
12. Hansen AB, Verder H, and Staun-Olsen P. Soluble intercellular adhesion molecule and C-reactive protein as early markers of infection in newborns. J Perinat Med 28: 97-103, 2000.
13. Hawgood S, Derrick M, and Poulain F. Structure and properties of surfactant protein B. Biochim Biophys Acta 1408: 150-160, 1998.
14. Head JF, Mealy TR, McCormack FX, and Seaton BA. Crystal structure of trimeric carbohydrate recognition and neck domains of surfactant protein A. J Biol Chem 278: 43254-43260, 2003.
15. Hearn SA and Possmayer F. Ultrastructure of tubular myelin in isolated pulmonary surfactant and 233 labeling for surfactant protein A. Scanning 19: 234, 1997.
16. Holm BA, Wang Z, and Notter RH. Multiple mechanisms of lung surfactant inhibition. Pediatr Res 46: 85-93, 1999.
17. Kew MM, Hyers TM, and Webster RO. Human C-reactive protein inhibits neutrophil chemotaxis in vitro: possible implications for the adult respiratory distress syndrome. J Lab Clin Med 115: 339-345, 1990.
18. Kukkonen AK, Virtanen M, Jarvenpaa AL, Pokela ML, Ikonen S, and Fellman V. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant? Acta Paediatr 89: 556-561, 2000.
19. Kuroki Y and Akino T. Pulmonary surfactant protein A (SP-A) specifically binds dipalmitoylphosphatidylcholine. J Biol Chem 266: 3068-3073, 1991.
20. Lewis JF and Veldhuizen R. The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 65: 613-642, 2003.
21. Li JJ, Sanders RL, McAdam KPWJ, Hales CA, Thompson BT, Gelfand JA, and Burke JF. Impact of C-reactive protein (CRP) on surfactant function. J Trauma 29: 1690-1697, 1989.
22. McCormack FX. Structure, processing and properties of surfactant protein A. Biochim Biophys Acta 1408: 109-131, 1998.
23. McCormack FX and Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 109: 707-712, 2002.
24. McEachren TM and Keough KM. Phosphocholine reverses inhibition of pulmonary surfactant adsorption caused by C-reactive protein. Am J Physiol Lung Cell Mol Physiol 269: L492-L497, 1995.
25. Mi LZ, Wang HW, and Sui SF. Interaction of rabbit C-reactive protein with phospholipid monolayers studied by microfluorescence film balance with an externally applied electric field. Biophys J 73: 446-451, 1997.
26. Mookerjea S and Hunt D. A novel phosphatidylcholine hydrolysing action of C-reactive protein. Biochem Biophys Res Commun 208: 1046-1052, 1995.
27. Nag K, Munro JG, Hearn SA, Sasmusson J, Petersen NO, and Possmayer F. Correlated atomic force and transmission electron microscopy of nanotubular structures in pulmonary surfactant. J Struct Biol 126: 1-15, 1999.
28. Nag K, Munro JG, Inchley K, Schürch S, Petersen NO, and Possmayer F. SP-B refining of pulmonary surfactant phospholipid films. Am J Physiol Lung Cell Mol Physiol 277: L1179-L1189, 1999.
29. Palaniyar N, Ikegami M, Korfhagen T, Whitsett J, and McCormack FX. Domains of surfactant protein A that affect protein oligomerization, lipid structure and surface tension. Comp Biochem Physiol A 129: 109-127, 2001.
30. Palaniyar N, Ridsdale RA, Hearn SA, Possmayer F, and Harauz G. Formation of membrane lattice structures and their specific interactions with surfactant protein A. Am J Physiol Lung Cell Mol Physiol 276: L642-L649, 1999.
31. Perez-Gil J and Keough KMW. Interfacial properties of surfactant proteins. Biochim Biophys Acta 1408: 203-217, 1998.
32. Piknova B, Schram V, and Hall S. Pulmonary surfactant: phase behavior and function. Curr Opin Struct Biol 12: 487-494, 2002.
33. Possmayer F. Physicochemical aspects of pulmonary surfactant. In: Fetal and Neonatal Physiology (3rd ed.), edited by Polin RA, Fox WW, and Abman SH. Philadelphia, PA: Saunders, 2004, p. 1014-1034.
34. Possmayer F, Nag K, Rodrjguez K, Qanbar R, and Schürch S. Surface activity in vitro: role of surfactant proteins. Comp Biochem Physiol A 129: 209-220, 2001.
35. Postle A. The analysis of lung surfactant phospholipids by electrospray ionization mass spectrometry: applications to disease states. Appl Cardiopulm Pathophysiol 9: 286-289, 2000.
36. Postle AD, Heeley EL, and Wilton DC. A comparison of the molecular species compositions of mammalian lung surfactant phospholipids. Comp Biochem Physiol A 129: 65-73, 2001.
37. Postle AD, Mander A, Reid KBM, Wang JY, Wright SM, Moustaki M, and Warner J. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol 20: 90-98, 1999.
38. Poulain FR, Allen L, Williams MC, Hamilton RL, and Hawgood S. Effects of surfactant apolipoproteins on liposome structure: implications for tubular myelin formation. Am J Physiol Lung Cell Mol Physiol 262: L730-L739, 1992.
39. Richards RL, Gewurz H, Siegel J, and Alving CR. Interactions of C-reactive protein and complement with liposomes. II. Influence of membrane composition. J Immunol 122: 1185-1189, 1979.
40. Robertson B and Halliday HL. Principles of surfactant replacement. Biochim Biophys Acta 1408: 346-361, 1998.
41. Rodriguez Capote K, Nag K, Schürch S, and Possmayer F. Surfactant protein interactions with neutral and acidic phospholipid films. Am J Physiol Lung Cell Mol Physiol 281: L231-L242, 2001.
42. Schürch S, Bachofen H, Goerke J, and Possmayer F. A captive bubble method reproduces the in situ behavior of lung surfactant monolayers. J Appl Physiol 67: 2389-2396, 1989.
43. Schürch S, Bachofen H, and Possmayer F. Surface activity in situ, in vivo, and in the captive bubble surfactometer. Comp Biochem Physiol A 129: 195-207, 2001.
44. Schürch S, Goerke J, and Clements JA. Direct determination of surface tension in the lung. Proc Natl Acad Sci USA 73: 4698-4702, 1976.
45. Schürch S, Green FHY, and Bachofen H. Formation and structure of surface films: captive bubble surfactometry. Biochim Biophys Acta 1408: 180-202, 1998.
46. Schürch S, Possmayer F, Cheng S, and Cockshutt AM. Pulmonary SP-A enhances adsorption and appears to induce surface sorting of lipid extract surfactant. Am J Physiol Lung Cell Mol Physiol 263: L210-L218, 1992.
47. Schwalbe RA, Dahlback B, Coe JE, and Nelsestuen GL. Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine. Biochemistry 31: 4907-4915, 1992.
48. Shrive AK, Cheetham GM, Holden D, Myles DA, Turnell WG, Volanakis JE, Pepys MB, Bloomer AC, and Greenhough TJ. Three dimensional structure of human C-reactive protein. Nat Struct Biol 3: 346-354, 1996.
49. Suzuki Y, Fujita Y, and Kogishi K. Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. Am Rev Respir Dis 140: 75-81, 1989.
50. Szalai AJ. The antimicrobial activity of C-reactive protein. Microbes Infect 4: 201-205, 2002.
51. Taskinen S, Kovanen PT, Jarva H, Meri S, and Pentikainen MO. Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein. Biochem J 367: 403-412, 2002.
52. Veldhuizen R, Nag K, Orgeig S, and Possmayer F. The role of lipids in pulmonary surfactant. Biochim Biophys Acta 1408: 90-108, 1998.
53. Venkitaraman AR, Hall SB, Whitsett JA, and Notter RH. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A. Chem Phys Lipids 56: 185-194, 1990.
54. Volanakis JE and Wirtz KW. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature 281: 155-157, 1979.
55. Voorhout WF, Veenendaal T, Haagsman HP, Verkleij A, van Golde LMG, and Geuze HJ. Surfactant protein A is localized at the corners of the pulmonary tubular myelin lattice. J Histochem Cytochem 39: 1331-1336, 1991.
56. Williams MC, Hawgood S, and Hamilton RL. Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C. Am J Respir Cell Mol Biol 5: 41-50, 1991.
57. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, Kim KS, and McCormack FX. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 111: 1589-1602, 2003.
58. Yu S, Harding PG, Smith N, and Possmayer F. Bovine pulmonary surfactant: chemical composition and physical properties. Lipids 18: 522-529, 1983.
59. Yu SH, McCormack FX, Voelker DR, and Possmayer F. Interactions of pulmonary surfactant protein SP-A with monolayers of dipalmitoylphosphatidylcholine and cholesterol. Roles of SP-A domains. J Lipid Res 40: 920-929, 1999.
60. Yu SH and Possmayer F. Effect of pulmonary surfactant protein A and neutral lipid on accretion and organization of dipalmitoylphosphatidylcho-line in surface films. J Lipid Res 37: 1278-1288, 1996.
61. Yu SH and Possmayer F. Reconstitution of surfactant activity by using the 6 kDa apoprotein associated with pulmonary surfactant. Biochem J 236: 85-89, 1986.